We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVBG
1126
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $3.37M | ﹤0.01% |
96,300
+63,400
| +193% | +$2.21M |
|
1127
Innoviva
INVA
$1.59B
| $3.36M | ﹤0.01% |
204,752
+182,575
| +823% | +$2.83M |
|
1128
Darden Restaurants
DRI
$24.2B
| $3.36M | ﹤0.01% |
22,190
+609
| +3% | +$92.7K |
|
1129
Telos
TLS
$338M
| $3.36M | ﹤0.01% |
834,864
-29,481
| -3% | -$112K |
|
|
PRFT
1130
DELISTED
Perficient Inc
PRFT
| $3.35M | ﹤0.01% |
+44,782
| New | +$2.86M |
|
1131
RPC Inc
RES
$1.15B
| $3.35M | ﹤0.01% |
+535,874
| New | +$3.75M |
|
1132
Cal-Maine
CALM
$4.45B
| $3.3M | ﹤0.01% |
54,078
+10,838
| +25% | +$643K |
|
1133
Gaming and Leisure Properties
GLPI
$13B
| $3.29M | ﹤0.01% |
+72,736
| New | +$3.21M |
|
1134
BlackLine
BL
$1.93B
| $3.28M | ﹤0.01% |
+67,681
| New | +$3.72M |
|
1135
Nerdy
NRDY
$109M
| $3.27M | ﹤0.01% |
1,960,393
+224,049
| +13% | +$492K |
|
|
EWCZ
1136
DELISTED
European Wax Center
EWCZ
| $3.27M | ﹤0.01% |
+329,670
| New | +$3.75M |
|
1137
US Physical Therapy
USPH
$1.22B
| $3.27M | ﹤0.01% |
35,392
+378
| +1% | +$38.2K |
|
1138
Horace Mann Educators
HMN
$2.12B
| $3.26M | ﹤0.01% |
100,004
-110,571
| -53% | -$3.87M |
|
1139
Porch Group
PRCH
$1.35B
| $3.25M | ﹤0.01% |
2,152,174
+226,721
| +12% | +$631K |
|
1140
Mercury Systems
MRCY
$5.56B
| $3.23M | ﹤0.01% |
119,854
-64,651
| -35% | -$1.89M |
|
1141
Central Garden & Pet Co
CENT
$2.77B
| $3.23M | ﹤0.01% |
84,000
+74,100
| +748% | +$3.1M |
|
1142
Travelers Companies
TRV
$81.1B
| $3.23M | ﹤0.01% |
15,885
-119,459
| -88% | -$25.7M |
|
1143
Apogee Therapeutics
APGE
$10.2B
| $3.22M | ﹤0.01% |
+81,946
| New | +$3.98M |
|
1144
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $3.22M | ﹤0.01% |
+41,800
| New | +$3.21M |
|
1145
CALL
iShares Semiconductor ETF
SOXX
$39.7B
| $3.21M | ﹤0.01% |
13,000
+12,800
| +6,400% | +$2.93M |
|
|
VRNT
1146
DELISTED
Verint Systems
VRNT
| $3.19M | ﹤0.01% |
+98,998
| New | +$3.16M |
|
1147
Vanguard Information Technology ETF
VGT
$135B
| $3.18M | ﹤0.01% |
44,168
+28,816
| +188% | +$1.92M |
|
1148
FLEX LNG
FLNG
$1.69B
| $3.18M | ﹤0.01% |
117,673
+76,321
| +185% | +$2.07M |
|
1149
Lindblad Expeditions
LIND
$1.97B
| $3.18M | ﹤0.01% |
329,166
-73,199
| -18% | -$567K |
|
1150
Silicon Laboratories
SLAB
$7.18B
| $3.17M | ﹤0.01% |
+28,671
| New | +$3.54M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.